Summary DNA ploidy analysis was performed on both fresh and paraffin-embedded preparations from each of 54 malignant ovarian neoplasms. Aneuploidy was detected in both the fresh and the paraffin-embedded tissue in 19 out of 54 (35%) malignant cases. In addition, aneuploidy was detected exclusively in fresh tissue in seven of the malignant cases, and exclusively in paraffin-embedded tissue in one of the malignant cases, yielding a total of 27 out of 54 (50%) aneuploid cases. The correlation coefficient (r-value) for fresh and paraffin-embedded tissue ploidy analysis in the malignant specimens was 0.91. Although the frequency of recurrence was higher and overall survival lower in the malignant aneuploid specimens of both types, the combined analysis of DNA and survival rates indicated superior prognostic significance of fresh tissue. Of the seven patients in whose specimens aneuploidy was detected exclusively in fresh tissue, all died of recurrent disease during the follow-up period. Our finding indicates that data generated by flow cytometry analysis of formalin-fixed tissue should be interpreted with caution before the data can be used to draw clinical inferences.
As evidence mounts that aneuploidy predicts a poor clinical outcome (Barlogie et al, 1980) , flow cytometry (FCM) is increasingly being used in DNA analysis to determine ploidy and proliferation rate in a variety of human neoplasms. Initially, the method was based upon examination of nuclear suspensions obtained from fresh or frozen material. Recently, however, numerous reports have confirmed flow cytometric detection of aneuploid subpopulations in paraffin-embedded tissues from human neoplasms (Schutte et al, 1985; Coon et al, 1986; Danova et al, 1988; Hedley, 1989) . The use of archival specimens has the important advantages of allowing rapid access to large numbers of specific tumours, and correlation with survival and treatment response data.
However, the question of whether the results obtained from fresh and paraffin-embedded tissues are comparable remains to be resolved. Although a few studies have examined DNA ploidy in both types of samples in small numbers of cases of particular tumours, such as melanoma and urogenital, bladder, lung, gastric, breast, haematopoietic, and lymphoid neoplasms (Camplejohn and Macartney, 1985; Nakamura et al, 1987; Jacobsen et al, 1988a,b; Klami and Joeysuu, 1988; Grignon et al, 1989; Isobe et al, 1990; Plestring et al, 1990; De Viata et al, 1991; Krause and Blank, 1992) , most studies have been restricted to either paraffinembedded or fresh tissues.
The aim of the present study was to address this issue by comparing DNA ploidy analysis in parallel fresh and paraffinembedded preparations from each of 82 ovarian tumours, with evaluation of the prospective prognostic significance in both cases.
MATERIAL AND METHODS Patients
Between May 1991 and March 1997 tissue samples were obtained from 54 women with primary malignant ovarian carcinoma and 28 women with benign ovarian neoplasm. All the malignant group were staged according to systems adopted by the International Federation of Gynecology and Obstetrics (FIGO) (Pattersson, 1989) . Clinical parameters, including surgical procedure, postoperative treatment, response to treatment and follow-up data, were collected from the medical records. All patients were followed up until death or March 1997.
Material
Propidium iodide stain (PI; from the Coulter DNA-Prep Reagent Kit, containing 50 gg ml-' PI, 4 KU ml-1 bovine pancreas type III RNAase, 0.1% sodium azide, saline and stabilizers) was obtained from Coulter Corporation (Miami, FL, USA). RPMI medium, formalin, ethyl alcohol, xylene, pepsin, sodium chloride and Hanks' solution were obtained from Sigma Chemical (St Louis, MO, USA).
Methods

Sample preparation
Fresh surgical biopsy ovarian specimens were cut into halves. One half of each tumour was paraffinized to form a tumour block representing the cell population in fresh tissue, as confirmed by haematoxylin and eosin staining. The second half was immediately put in ice-cold RPMI medium. From each sample, a single-cell suspension was made within 30 min of sampling after removal of fat, blood accumulations, necrotic tissue and normal-looking tissue. Sections (50 jum) from each paraffin block were deparaffinized according to Hedley's method, modified by McLemore et al, 1990 . Then, 1 ml of 0.5% prewarmed pepsin in 0.9% saline at pH 1.5 was added to each sample, followed by incubation for 45-60 min at 36°C, with vortexing at intervals of 10 min. All of the residual solid tissue was then removed, and the remaining nuclear suspension was filtered through a 50-jim nylon mesh. The suspension was then centrifuged at 800 g for 5 min, and the supernatant was decanted. The pellet was resuspended in 1 ml of Hanks' solution, centrifuged as before, and the supematant was decanted. The wash step was repeated twice. The final concentration was adjusted to 106 nuclei ml-'.
After disaggregation, both fresh and paraffinized samples were stained with propidium iodide, as follows: a 100-jl aliquot of each sample was lysed and stained by the Coulter DNA-Prep, which sequentially dispenses and mixes 100 jl of lysing permeabilizing reagent (LPR) and 1 ml of staining solution (containing 50 jg ml-1 propidium iodide and 4 kU ml-' bovine pancreas type III RNAase) into each sample. Finally, the samples were incubated at room temperature for 60 min in darkness before flow cytometric analysis.
Flow cytometry Flow cytometric analysis was performed with a Coulter EPICS Profile II flow cytometer, configured with a 488-nm argon ion laser. Peripheral blood lymphocytes were used as an external standard for fresh tissue material. For paraffin-embedded tissue, 50-jm sections from tonsil block were processed in parallel with each run and were used as an external standard. A total of 20 000 events per sample were acquired. DNA aneuploidy was defined as any population with a distinct additional peak(s) or the presence of a tetraploid population greater than 15%. The CV was defined as the standard deviation as a percentage of the mean DNA value of the diploid peak. Samples were excluded when CV exceeded 5%.
Statistical analysis
Univariate analyses were performed using a chi-square test of association or Fisher's exact model to test the association of categorical variables with relapse and survival. To analyse the simultaneous effect of all variables and control for varied follow-up, Cox's proportional hazards model with Breslow's approximate likelihood method to handle ties was performed (Cox and Oakes, 1984) . The assumptions of Cox's proportional hazards model were assessed, including interactions and proportionality of hazards over time. For all analyses, two-sided tests of significance were performed. All analyses were performed using the Statistical Package for the Social Sciences (SPSS) software.
RESULTS
The clinical follow-up period was 5-66 months (mean 36 months). During the follow-up period, 48% of cases relapsed. Of relapsed cases, 77% of them died during the follow-up period. Only nine cases had stage I-II, whereas 83% had FIGO stage III tumours. A total of 35% had grade I tumours and 65% had grade II-III. Postsurgical tumour burden in all patients was less than 2 cm. The results of the univariate analysis are shown in Table 1 . Irrespective of the variation in the follow-up, significant differences in overall survival and disease-free survival were found between groups of patients with respect to stage, grade, and DNA ploidy results obtained from both fresh and paraffin-embedded tissues. In the multivariate analysis, DNA ploidy in fresh tissue was the most significant predictive variable for both relapse and overall survival. Stage, grade and DNA ploidy in paraffinized tissue also attained significance. In the second and third steps, DNA ploidy in paraffinized tissue and stage were introduced into the final Cox model as shown in Table 2 . However, if ploidy results in fresh tissue were excluded from this final model and DNA ploidy results in paraffinized tissue were added, it was found to be significant (P = 0.01). In stage III tumours, only results of DNA ploidy in fresh tissue were predictive of relapse and survival in the multivariate analysis (Table 3) .
A comparison of DNA ploidy obtained from fresh and paraffinembedded tissues yielded a correlation coefficient of 0.91 ( Figure  1) (Figure 2) , and exclusively in the paraffin-embedded section in one case. Of the seven cases in whose specimens aneuploidy was detected in fresh tissue exclusively all died of recurrent disease during the follow-up period.
DISCUSSION
The prognostic significance of flow cytometry DNA ploidy in ovarian carcinoma has been controversial (Erba et al, 1989; Sahni et al, 1989) . Discrepancies between studies may reflect both methodological and biological aspects. The majority of the studies, however, were based on either fresh or paraffin-embedded specimens. The current study is among the first to examine the prospective significance of DNA ploidy determined in fresh vs paraffin-embedded tissue on a group of patients with complete and clear follow-up data. In this study, we examined 82 ovarian tumours (54 malignant and 28 benign), from each of which both fresh and paraffin preparations were made, with the aim of evaluating the use of the fixed samples by a prospective follow-up.
Overall, both methods detected aneuploidy in 19 out of 54 (35%) malignant specimens and 0 out of 28 (0%) benign samples, British Journal of Cancer (1998) yielding a correlation coefficient, or r-value, of 0.91, which compared favourably with other studies in other neoplasms, with reported values of 0.55-0.97 (Camplejohn and Macartney, 1985; Nakamura et al, 1987; Jacobsen et al, 1988a,b; Klami and Joeysuu, 1988; Grignon et al, 1989; Isobe et al, 1990; Plestring et al, 1990; De Viata et al, 1991; Krause and Blank, 1992) . The opposing viewpoint, that the flow cytometry ploidy analysis of fixed tumours may not be satisfactorily reproduced, is supported by studies that showed DI discrepancies in fresh compared with fixed tissues (Kallioniemi, 1988; Price and Herman, 1990) . However, detection of aneuploidy was less sensitive in paraffinembedded tissue than in fresh tissue. Seven additional aneuploid cases were detected in fresh tissue exclusively, and one additional aneuploid case was detected in paraffin-embedded tissue exclusively. Thus, the overall rate of aneuploidy detection was 26 out of 54 (48%) in the fresh tissue, and 20 out of 54 (37%) in the paraffin-embedded tissue. Possible explanations for this discrepancy in frequency of DNA aneuploidy in fresh compared with paraffin-embedded tissue included heterogeneity of the tumour itself, differences in tissue fixation and loss or fragility of tumour nuclei during processing.
The suspension obtained from fresh samples is more representative of a whole tumour, whereas in fixed tissues we only analysed a section of 50 gm. For this reason, we agree with others (Ljungberg et al, 1985; De Vita et al, 1991 ) that analysis with paraffinembedded tissue should preferably be performed on different samples of the same tumour. In fact, the cases that did not correspond were further analysed in sequential sections and stained overnight. The disappearance of the aneuploid peak found in the cases analysed in sequential sections indicate the absence of actual intratumour heterogeneity in these cases and confirm previous studies that have characterized DNA ploidy in ovarian carcinoma as being stable (Friedlander et al, 1984; Volm et al, 1985) .
The importance of tissue fixation has been appreciated subsequent to the original description of flow cytometry analysis in paraffin-embedded tissues. Unsatisfactory results of DNA flow cytometry from paraffin-embedded tissue are more likely to be caused by failure in fixation rather than the inadequate application of the flow cytometry method (Feichter and Goerttler, 1986) . External standards can be used in fresh preparations but this is not possible with paraffin analysis. Differences in fixation and/or processing as well as differences in chromatin structure of the control tissue compared with the tumour tissue, can affect the binding of dyes, specifically the intercalating dyes, resulting in different fluorescent intensity of diploid nuclei. In the present study, both ovarian tissue and tonsil tissue were immediately fixed within 30 min from sampling in a standardized manner. One tonsil tissue section was processed in parallel with each run of ovarian specimens. If the tonsil control G!G1 peak CV exceeded 2 s.d. of our established mean, the optimum instrument performance, staining were verified and all samples prepared with tonsil control were reprocessed.
We agree with Schultz and Zarbo that nuclear deterioration, before or during formalin fixation or during pepsin digestion, may be the cause of the significant decrease in sensitivity of the paraffln digestion method shown in the present work (Schultz and Zarbo, 1992) .
Univariate analysis of our data confirmed the prognostic significance of known surgical-pathological factors, including FIGO stage and histological grade (Barabei et al, 1990) . We also used disease-free survival as a measure of poor outcome because very few patients with recurrent disease survived (6 out of 26). Using this end point, 48% of patients were classified as having persistent or recurrent disease, which allowed for a meaningful statistical analysis. Univariate analysis of evaluated factors demonstrated the prognostic significance of stage and DNA ploidy results in fresh and paraffin-embedded tissues with relapse. Multivariate analysis of these results, controlled for varied follow-up time, showed that DNA ploidy obtained by fresh tissue analysis was an independent prognostic factor, superior to other factors for both relapse and survival. However, when results obtained from the fresh tissue method were excluded from the final Cox model, DNA ploidy analysis carried out on paraffinized samples attained significance. Of the seven cases in whose specimens aneuploidy was detected in fresh tissue exclusively, all died of recurrent disease during the follow-up period. Using DNA ploidy, a clear distinction was found between a favourable group with a median survival of more than 48 months and the remaining patients of whom the majority died during the same follow-up period. When patients were separated into low stage (I-II) and advanced stage disease (III), DNA content was a significant prognostic variable for both relapse and survival in stage III tumours.
Taken together, our findings indicate that data generated by flow cytometry analysis of formalin-fixed tissue should be interpreted with caution before the data can be used to draw clinical inferences.
